Healthcare Integrated Technologies, Inc.
HITC
$0.3027
$0.057523.45%
| Weiss Ratings | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.17 | |||
| Price History | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.14% | |||
| 30-Day Total Return | -1.59% | |||
| 60-Day Total Return | 137.41% | |||
| 90-Day Total Return | 89.19% | |||
| Year to Date Total Return | 113.02% | |||
| 1-Year Total Return | 449.36% | |||
| 2-Year Total Return | 133.20% | |||
| 3-Year Total Return | 236.33% | |||
| 5-Year Total Return | 59.32% | |||
| 52-Week High % Change | -36.67% | |||
| 52-Week Low % Change | 505.40% | |||
| Price | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.48 | |||
| 52-Week Low Price | $0.05 | |||
| 52-Week Low Price (Date) | Aug 01, 2024 | |||
| 52-Week High Price (Date) | Jan 24, 2025 | |||
| Valuation | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 34.57M | |||
| Enterprise Value | 28.91M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -20.86% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 79.66 | |||
| Price/Book (Q) | 18.13 | |||
| Enterprise Value/Revenue (TTM) | 89.80 | |||
| Price | $0.30 | |||
| Enterprise Value/EBITDA (TTM) | -27.25 | |||
| Enterprise Value/EBIT | -22.56 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 83.44M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 865 237 4448 | |||
| Address | 311 S. Weisgarber Road Knoxville, TN 37919 | |||
| Website | gethitc.com | |||
| Country | United States | |||
| Year Founded | 2013 | |||
| Profitability | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -398.04% | |||
| Profit Margin | -359.65% | |||
| Management Effectiveness | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -45.05% | |||
| Return on Equity | -- | |||
| Income Statement | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 322.00K | |||
| Total Revenue (TTM) | 322.00K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 82.10K | |||
| EBITDA (TTM) | -1.06M | |||
| EBIT (TTM) | -1.28M | |||
| Net Income (TTM) | -1.16M | |||
| Net Income Avl. to Common (TTM) | -1.16M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -199.39% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | -141.18% | |||
| Balance Sheet | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.01M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 2.27M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.76M | |||
| Current Ratio (Q) | 2.401 | |||
| Book Value Per Share (Q) | $0.02 | |||
| Total Assets (Q) | 2.70M | |||
| Total Current Liabilities (Q) | 944.20K | |||
| Total Debt (Q) | 650.90K | |||
| Total Liabilities (Q) | 944.20K | |||
| Total Common Equity (Q) | 1.76M | |||
| Cash Flow | HITC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 2.66M | |||
| Net Change in Cash (TTM) | 2.01M | |||
| Levered Free Cash Flow (TTM) | -911.80K | |||
| Cash from Operations (TTM) | -643.40K | |||
